CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/22
Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9, 期号: 6, 页码: 15
作者:  Mu, Wei;  Jiang, Lei;  Shi, Yu;  Tunali, Ilke;  Gray, Jhanelle E.
收藏  |  浏览/下载：72/0  |  提交时间：2021/08/15
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  Yu, Hui;  Sun, Si;  Hu, Xingjiang;  Xia, Jinjing;  Wang, Jialei
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study 期刊论文
2019, 卷号: 31, 期号: 3, 页码: 481-+
作者:  Xing, Puyuan;  Ma, Di;  Wang, Qiang;  Hao, Xuezhi;  Wang, Mengzhao
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment 期刊论文
2019, 卷号: 31, 期号: 2, 页码: 349-356
作者:  Xu, Haiyan;  Ma, Di;  Yang, Guangjian;  Li, Junling;  Hao, Xuezhi
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance 期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1096-1102
作者:  Xu, Haiyan;  Yang, Guangjian;  Yang, Lu;  Yang, Yaning;  Ma, Di
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: Vol.13 No.10, 页码: 1539-1548
作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai
收藏  |  浏览/下载：7/0  |  提交时间：2019/02/25
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文
2018, 卷号: 13, 期号: 10, 页码: 1539-1548
作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
An UPLC-MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients 期刊论文
2018, 卷号: 153, 页码: 1-8
作者:  Cui, Cheng;  Hu, Pei;  Jiang, Ji;  Kong, Fansheng;  Luo, Hong
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace